PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma
- PMID: 31084776
- DOI: 10.1016/j.cpet.2019.03.009
PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma
Abstract
In the past decade novel treatment options have dramatically prolonged the survival of patients with multiple myeloma. PET combined with computed tomography (CT) is a sensitive and reliable functional imaging tool that enables diagnosis and assessment of response to chemotherapy/radiotherapy, and combines high sensitivity in identifying both lytic lesions and extramedullary soft-tissue masses with the ability to provide reliable prognostic information in the management of patients with myeloma. This review comprises a comprehensive overview of PET with fluorodeoxyglucose F 18/CT imaging in combination with other convenient imaging procedures, and attempts at standardization with emphasis on post-therapy findings in patients with myeloma.
Keywords: Multiple myeloma; PET/CT; Staging.
Copyright © 2019 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
